Klaus Lechner

28.9k total citations · 3 hit papers
453 papers, 18.8k citations indexed

About

Klaus Lechner is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Klaus Lechner has authored 453 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Hematology, 120 papers in Genetics and 105 papers in Immunology. Recurrent topics in Klaus Lechner's work include Acute Myeloid Leukemia Research (96 papers), Blood Coagulation and Thrombosis Mechanisms (67 papers) and Mast cells and histamine (64 papers). Klaus Lechner is often cited by papers focused on Acute Myeloid Leukemia Research (96 papers), Blood Coagulation and Thrombosis Mechanisms (67 papers) and Mast cells and histamine (64 papers). Klaus Lechner collaborates with scholars based in Austria, Germany and United States. Klaus Lechner's co-authors include Peter Valent, Paul A. Kyrle, Ingrid Pabinger, Peter Bettelheim, Wolfgang R. Sperr, Klaus Geißler, David Green, Christine Mannhalter, Ulrich Jäger and Barbara Schneider and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Klaus Lechner

447 papers receiving 18.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

2008 1.9k citations Klaus Lechner, Miguel Á. Sanz et al. profile →
A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII

1981 569 citations Klaus Lechner et al. profile →
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism

2000 568 citations Paul A. Kyrle, Klaus Lechner et al. profile →

Peers

Countries citing papers authored by Klaus Lechner

Since Specialization

Citations

This map shows the geographic impact of Klaus Lechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Lechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Lechner more than expected).

Fields of papers citing papers by Klaus Lechner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Lechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Lechner. The network helps show where Klaus Lechner may publish in the future.

Co-authorship network of co-authors of Klaus Lechner

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Lechner. A scholar is included among the top collaborators of Klaus Lechner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Lechner. Klaus Lechner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vitamin B12 deficiency: New data on an old disease 2005 ·Wiener klinische Wochenschrift ·Klaus Lechner, Manuela Födinger, Wolfgang Grisold, Andreas Püspök, Christian Sillaber	14
2	Detection of Trisomy 8 in Donor-Derived Ph⁻Cells in a Patient with Ph⁺Chronic Myeloid Leukemia Successfully Treated with Imatinib (STI571) in Relapse after Allogeneic Transplantation 2004 ·Leukemia & lymphoma ·Hermine Agis, Christine Mannhalter, Wolfgang R. Sperr, Felix Keil, Peter Kalhs, Hendrati Pirc‐Danoewinata, Maria‐Theresa Krauth, Oskar A. Haas, Klaus Geißler, Klaus Lechner, Peter Valent	6
3	Massive postoperative intramuscular bleeding in acquired von Willebrand's disease 2002 ·Annals of Hematology ·Michael Krebs, Bernhard M. Meyer, Peter Quehenberger, Peter L. Turecek, Michael Hejna, Wolfgang R. Sperr, Klaus Lechner, Ingrid Pabinger	5
4	Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma 2001 ·Annals of Hematology ·Nina Worel, Hildegard Greinix, J Ackermann, H. Kaufmann, (unknown), (unknown), Heinz Gisslinger, Klaus Lechner, Peter Kalhs, Johannes Drach	23
5	1,25-Dihydroxyvitamin D3 inhibits dendritic cell differentiation and maturation in vitro 2000 ·Experimental Hematology ·A. Berer, Johannes Stöckl, Otto Majdic, Thomas Wagner, Marietta Kollars, Klaus Lechner, Klaus Geißler, Leopold Oehler	175
6	Fludarabine therapy in Waldenström's macroglobulinemia 2000 ·Annals of Hematology ·Renate Thalhammer-Scherrer, Klaus Geißler, Ilse Schwarzinger, Andreas Chott, Heinz Gisslinger, Paul Knöbl, Klaus Lechner, Ulrich Jäger	26
7	Generation of Dendritic Cells from Human Chronic Myelomonocytic Leukemia Cells in Fetal Calf Serum-Free Medium 2000 ·Leukemia & lymphoma ·Leopold Oehler, A. Berer, Felix Keil, (unknown), Margit König, Oskar A. Haas, Klaus Lechner, Klaus Geißler	9
8	Mast cells are augmented in deep vein thrombosis and express a profibrinolytic phenotype 1999 ·Human Pathology ·(unknown), (unknown), (unknown), (unknown), (unknown), Hans Bankl, Klaus Lechner, Peter Valent	19
9	Inhibition of Allergen-Induced Histamine Release from Human Basophils by Cyclosporine A and FK-506 1997 ·International Archives of Allergy and Immunology ·Wolfgang R. Sperr, Hermine Agis, H. Semper, Rudolf Valenta, Markus Susani, (unknown), Martin Willheim, Otto Scheiner, E. Liehl, Klaus Lechner, Peter Valent	19
10	Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes 1996 ·Immunology ·Hermine Agis, Wolfgang Füreder, Hans Bankl, Michael Kundi, Wolfgang R. Sperr, Martin Willheim, G Boltz-Nitulescu, Joseph H. Butterfield, Kenji Kishi, Klaus Lechner, Peter Valent	117
11	Multidrug Resistance in Leukemias and its Reversal 1996 ·Leukemia & lymphoma ·R. Malayeri, Martin Filipits, (unknown), Sabine Zöchbauer‐Müller, Klaus Lechner, Robert Pirker	28
12	Mast Cell-Lineage Versus Basophil Lineage Involvement in Myeloproliferative and Myelodysplastic Syndromes: Diagnostic Role of Cell-Immunopheno typing 1996 ·Leukemia & lymphoma ·Hermine Agis, Waltraud J. Beil, Hans Bankl, Wolfgang Füreder, Wolfgang R. Sperr, Minoo Ghannadan, Mehrdad Baghestanian, Christian Sillaber, Peter Bettelheim, Klaus Lechner, Peter Valent	34
13	Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. 1996 ·The Journal of Experimental Medicine ·Klaus Geißler, Leopold Öhler, Manuela Födinger, Irene Virgolini, M. Leimer, Eva Kabrna, Marietta Kollars, Sonja Skoupy, Barbara Bohle, Michael A. Rogy, Klaus Lechner	49
14	Results of a randomised, double-blind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de-novo acute myeloid leukemia 1995 ·Ghent University Academic Bibliography (Ghent University) ·Gerhard Heil, Miguel Á. Sanz, Klaus Lechner, Jun Yin, L. Noens, (unknown), Jcm Ho, D. Hoelzer, Chris O’Brien, James Matcham, Alan Barge	12
15	Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. 1993 ·PubMed ·Christian Sillaber, Dorian Bevec, Joseph H. Butterfield, Christina Heppner, Rudolf Valenta, Otto Scheiner, Dietrich Kraft, Klaus Lechner, Peter Bettelheim, Peter Valent	58
16	Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c- kit +, CD34+, Ly-, CD14-, CD17-, colony-forming cell. 1993 ·The Journal of Immunology ·Hermine Agis, Martin Willheim, Wolfgang R. Sperr, Astrid Wilfing, Elisabeth Krömer, Eva Kabrna, (unknown), Herbert Strobl, Klaus Geißler, Andreas Spittler, G Boltz-Nitulescu, Otto Majdic, Klaus Lechner, Peter Valent	106
17	Transient lupus anticoagulant associated with hypoprothrombinemia and Factor XII deficiency following adenovirus infection 1993 ·Annals of Hematology ·Ulrich Jaeger, S. Kapiotis, Ingrid Pabinger, Elisabeth Puchhammer, Paul A. Kyrle, Klaus Lechner	54
18	Treatment of Severe Aplastic Anemia with Combined Immunosuppression (Antithymocyte Globulin and High-Dose Methylprednisolone) 1986 ·Acta Haematologica ·M Hinterberger-Fischer, W Hinterberger, (unknown), (unknown), Helmut Gadner, Klaus Geißler, Mitja Kos, (unknown), E Neumann, H. Niessner, Joanne Schindler, Klaus Lechner	10
19	Circulating Committed and Pluripotent Haemopoietic Progenitor Cells, in Infants 1986 ·Acta Haematologica ·Klaus Geißler, (unknown), W Hinterberger, Klaus Lechner, P Wurnig	15
20	[Protein C deficiency and thrombosis diathesis]. 1984 ·PubMed ·Ingrid Pabinger-Fasching, Klaus Lechner	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact